{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:56:40Z","timestamp":1774497400832,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.108020","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T03:14:26Z","timestamp":1627528466000},"page":"108020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus"],"prefix":"10.1016","volume":"99","author":[{"given":"Praveenkumar","family":"Murugavelu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Perween","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tripti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanshika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Ahmad Parray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh Kumar","family":"Chiranjivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamini","family":"Jakhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipta","family":"Sonar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankar","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandresh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritika","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supratik","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweety","family":"Samal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Kshetrapal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjini","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpana","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108020_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.596201","article-title":"Wuhan to World: The COVID-19 Pandemic","volume":"11","author":"Kumar","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2021.108020_b0010","unstructured":"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications, (n.d.). https:\/\/www.nature.com\/articles\/s41467-020-18450-4 (accessed June 29, 2021)."},{"key":"10.1016\/j.intimp.2021.108020_b0015","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1038\/s41598-021-91746-7","article-title":"Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry","volume":"11","author":"Mannar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2021.108020_b0020","unstructured":"Structures and Mechanisms of Viral Membrane Fusion Proteins, (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2649671\/ (accessed March 17, 2021)."},{"issue":"4","key":"10.1016\/j.intimp.2021.108020_b0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bmjebm-2020-111549","article-title":"Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil","volume":"26","author":"Fink","year":"2021","journal-title":"BMJ Evid. Based Med."},{"key":"10.1016\/j.intimp.2021.108020_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-021-02702-2","article-title":"Effect of influenza vaccine on COVID-19 mortality: a retrospective study","author":"Candelli","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.intimp.2021.108020_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/INF.0b013e318201811c","article-title":"WAIVE Study Team, Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case-Control Study","volume":"30","author":"Kelly","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.intimp.2021.108020_b0040","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2021.108020_b0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cit379","article-title":"Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness","volume":"57","author":"Sundaram","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.intimp.2021.108020_b0050","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"16","key":"10.1016\/j.intimp.2021.108020_b0055","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108020_b0060","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.intimp.2021.108020_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.629873","article-title":"Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production","volume":"8","author":"Zhao","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"36","key":"10.1016\/j.intimp.2021.108020_b0070","doi-asserted-by":"crossref","first-page":"12814","DOI":"10.1074\/jbc.AC120.014918","article-title":"Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a na\u00efve semi-synthetic library","volume":"295","author":"Parray","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2021.108020_b0075","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.vaccine.2018.01.081","article-title":"Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response","volume":"36","author":"Shrivastava","year":"2018","journal-title":"Vaccine."},{"issue":"7","key":"10.1016\/j.intimp.2021.108020_b0080","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1128\/JVI.03090-15","article-title":"Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop","volume":"90","author":"Patil","year":"2016","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108020_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3136","article-title":"A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments","volume":"37","author":"Perween","year":"2021","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.intimp.2021.108020_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641447","article-title":"Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model","volume":"12","author":"Shrivastava","year":"2021","journal-title":"Front. Immunol."},{"issue":"39","key":"10.1016\/j.intimp.2021.108020_b0095","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1016\/j.vaccine.2020.07.058","article-title":"Influenza immunization and COVID-19","volume":"38","author":"Maltezou","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.intimp.2021.108020_b0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","article-title":"The Quest for a Truly Universal Influenza Vaccine","volume":"9","author":"Jang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2021.108020_b0105","unstructured":"The effect of influenza vaccination on trained immunity: impact on COVID-19 | medRxiv, (n.d.). https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.14.20212498v1 (accessed March 17, 2021)."},{"issue":"7821","key":"10.1016\/j.intimp.2021.108020_b0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2021.108020_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2021.108020_b0120","article-title":"Influenza Vaccination and COVID19 Mortality in the USA","author":"Zanettini","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.intimp.2021.108020_b0125","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2021.108020_b0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrmicro1707","article-title":"Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy","volume":"5","author":"Balzarini","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2021.108020_b0135","unstructured":"Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy, (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4136306\/ (accessed March 17, 2021)."},{"issue":"7815","key":"10.1016\/j.intimp.2021.108020_b0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.108020_b0145","doi-asserted-by":"crossref","first-page":"100375","DOI":"10.1016\/j.jbc.2021.100375","article-title":"How glycobiology can help us treat and beat the COVID-19 pandemic","volume":"296","author":"Lardone","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2021.108020_b0150","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.80.5.2515-2528.2006","article-title":"Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1","volume":"80","author":"Moore","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2021.108020_b0155","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV","author":"Ladner","year":"2020","journal-title":"BioRxiv."},{"issue":"12","key":"10.1016\/j.intimp.2021.108020_b0160","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/CVI.00278-10","article-title":"Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum","volume":"17","author":"Gorse","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.intimp.2021.108020_b0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijid.2020.10.104","article-title":"High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa","volume":"102","author":"Tso","year":"2021","journal-title":"Int J Infect Dis."},{"issue":"1","key":"10.1016\/j.intimp.2021.108020_b0170","doi-asserted-by":"crossref","first-page":"100189","DOI":"10.1016\/j.xcrm.2020.100189","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Rep Med."},{"issue":"7","key":"10.1016\/j.intimp.2021.108020_b0175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2021.108020_b0180","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2021.108020_b0185","article-title":"Spread of SARS-CoV-2 Coronavirus likely constrained by climate","author":"Ara\u00fajo","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.intimp.2021.108020_b0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2017.11.002","article-title":"Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host","volume":"28","author":"Zheng","year":"2018","journal-title":"Curr Opin. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108020_b0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/mab.2020.0029","article-title":"A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection","volume":"39","author":"Kohler","year":"2020","journal-title":"Monoclon Antib. Immunodiagn. Immunother."},{"issue":"3","key":"10.1016\/j.intimp.2021.108020_b0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin."},{"key":"10.1016\/j.intimp.2021.108020_b0205","unstructured":"Is COVID-19 receiving ADE from other coronaviruses? - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/32092539\/ (accessed March 17, 2021)."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:14:55Z","timestamp":1730837695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921006561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":41,"alternative-id":["S1567576921006561"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108020","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108020"}}